Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record.

Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two‐year multicenter, prospective, randomized, double‐blind, placebo‐controlled study

Chen, Chung‐Hwan, Chang, Je‐Ken, Lai, Kuo‐An, Hou, Sheng‐Mou, Chang, Chih‐Hao, Wang, Gwo‐Jaw·2012·Arthritis & Rheumatism

Abstract

Objective: Osteonecrosis is one of the major debilitating skeletal disorders. Most patients with osteonecrosis of the femoral head eventually need surgery, usually total hip arthroplasty (THA), within a few years of onset. Previous studies showed that alendronate has a pharmacologic effect in reducing osteoclast activity and that it significantly reduced the incidence of collapse of the femoral head in the osteonecrotic hip. The purpose of this study was to determine the cumulative incidence of THA in patients with osteonecrosis of the femoral head and the time‐to‐event after treatment with alendronate versus placebo during the study period. Methods: A 2‐year multicenter, prospective, randomized, double‐blind study was performed. From June 2005 to December 2006, 64 patients were enrolled and randomly assigned to the alendronate or placebo group. In patients with bilateral hip osteonecrosis who met the inclusion criteria, both hips were counted in the analyses. Five patients were excluded from the analysis because they did not comply with any of the study regimens. Seven patients were ineligible because they were not diagnosed as having stage IIC or stage IIIC disease according to the University of Pennsylvania system. Thus, a total of 52 patients (65 hips) were assessed in this study. Disease progression was evaluated by radiography and magnetic resonance imaging (MRI). The Harris Hip Score and the Short Form 36 health survey were used to rate hip function and quality of life, respectively. Results: There was no significant difference in radiographic and MRI data between the 2 study groups. Four of 32 hips in the alendronate treatment group underwent THA, while 5 of 33 hips in the placebo group had THA (P = 0.837). No differences were noted in disease progression, Harris Hip Scores, or Short Form 36 scores between the 2 groups. Conclusion: Alendronate has no obvious effect on preventing the necessity for THA, reducing disease progression, or improving life quality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.33498

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 163

Metadata

Authors
Chen, C., Chang, J., Lai, K., Hou, S., Chang, C., & Wang, G.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2012-04-26
Volume
64
Issue
5
Pages
1572-1578
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1967894844
Cited by
163
References
0
FWCI
9.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two‐year multicenter, prospective, randomized, double‐blind, placebo‐controlled study. https://app.cochat.ai/papers/10.1002/art.33498
The paper
Chen, C., Chang, J., Lai, K., Hou, S., Chang, C., & Wang, G. (2012). Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two‐year multicenter, prospective, randomized, double‐blind, placebo‐controlled study. Arthritis & Rheumatism. https://doi.org/10.1002/art.33498

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.